|
Status |
Public on Jan 29, 2022 |
Title |
DMS53 siNEUROD1 T1 |
Sample type |
SRA |
|
|
Source name |
Cell line
|
Organism |
Homo sapiens |
Characteristics |
cell type: DMS-53 treatment: siRNA NEUROD1 treatment: treated with biotinilated PM01183 50nM for 4 hours
|
Treatment protocol |
DMS53 cells were seeded in 15 cm dishes and grown to subconfluency before treatment with 50nM Lurbinectedin.
|
Growth protocol |
All cell lines were cultured in the medium and conditions recommended by the supplier and supplemented with 10%FBS, 2nmol/L L-glutamine, and penicillin-streptomycin mix (Sigma).
|
Extracted molecule |
total RNA |
Extraction protocol |
none provided by the submitter RNA-seq polyA
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina MiniSeq |
|
|
Data processing |
Processed using nf-core RNA-Seq pipeline v1.3.3 Alingment with HISAT 2.1.0 Read count with Subread featureCounts v1.6.4 DEG analisyed with Deseq2 from featurecounts matrix FPKM calculated with Stringtie 1.3.5 Genome_build: hg19 Supplementary_files_format_and_content: tab-delimited text files include reads values for each Sample Supplementary_files_format_and_content: Matrix table with raw gene counts for every gene and every sample
|
|
|
Submission date |
Jun 28, 2021 |
Last update date |
Jan 29, 2022 |
Contact name |
Federico Costanzo |
E-mail(s) |
[email protected]
|
Organization name |
Institute of Oncology Research IOR
|
Street address |
Via Vela 6
|
City |
Bellinzona |
ZIP/Postal code |
6500 |
Country |
Switzerland |
|
|
Platform ID |
GPL22790 |
Series (2) |
|
Relations |
BioSample |
SAMN19923427 |
SRA |
SRX11245154 |